Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients.

Gabrielle Jongeneel,Marjolein J E Greuter,Felice N. van Erning,Miriam Koopman,Geraldine R. Vink,Cornelis J. A. Punt,Veerle M.H. Coupé

Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients.

2021

Gabrielle Jongeneel
Marjolein J E Greuter
Felice N. van Erning
Miriam Koopman
Geraldine R. Vink
Cornelis J. A. Punt
Veerle M.H. Coupé

Background:We aimed to evaluate the cost-effectiveness of risk-based strategies to improve the selection of surgically treated stage II colon cancer (CC) patients for adjuvant chemotherapy.Methods:...

Keywords:

stage ii
Internal medicine
Adjuvant
Medicine
Oncology
Colorectal cancer
Personalized medicine
adjuvant chemotherapy
cost effectiveness
Stage ii colon cancer
Selection (genetic algorithm)

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations